Tech Company Financing Transactions
PleoPharma Funding Round
National Institute on Drug Abuse (NIDA) joined a $6.5 million funding round for PleoPharma. The funding round was announced on 8/20/2026.
Transaction Overview
Company Name
Announced On
8/20/2026
Transaction Type
Debt
Amount
$6,500,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to support the advancement of its pivotal Phase 3 CAN-004 clinical trial of PP-01.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
518 Kimberton Road 339
Phoenixville, PA 19460
USA
Phoenixville, PA 19460
USA
Phone
Website
Email Address
Overview
Our Mission is to develop a treatment that helps meet the growing demand of an unmet and significant medical condition. PleoPharma is a pharmaceutical company that holds its employees and consultants to the highest moral and ethical standards. PleoPharma is committed to developing medications for a new indication and strives to deliver a strong return to our shareholders and investors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ginger Constantine
Browse more venture capital transactions:
Prev: 8/20/2026: Velatir venture capital transaction
Next: 8/20/2026: Avatar Robotics venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. All VC database entries reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs